|Articles|June 16, 2021
Roche Pharma’s new approach to Upstream Process Development
Author(s)Roche
Roche Pharma Research and Early Development lab automation specialist, Pawel Linke, discusses their approach to doubling the number of projects in process development without significantly increasing headcount.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
5